Cleavage and release of the soluble TLR2 ectodomain suppresses TLR2 activity by binding and quenching DAMP ligands, an activity thought to reduce the development of autoimmunity through a negative feedback loop [61]. The gene discussed is TLR2; the disease is Autoimmunity.